Tanya Boatwright
Family · Sebring, FLNPI 1962989491
Payments from drug & device makers
Across 82 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$279
- Agile Therapeutics, Inc.$227
- Exeltis, USA Inc.$140
- Hologic Sales And Service, LLC$136
- Evofem Biosciences, Inc.$130
- Mayne Pharma Commercial LLC$98
- plus $663 from 18 others
What the payments were for
- Food & beverage$1,674100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $279 |
| Agile Therapeutics, Inc. | 12 | $227 |
| Exeltis, USA Inc. | 9 | $140 |
| Hologic Sales And Service, LLC | 6 | $136 |
| Evofem Biosciences, Inc. | 6 | $130 |
| Mayne Pharma Commercial LLC | 5 | $98 |
| Millicent US Inc | 5 | $91 |
| Pfizer | 4 | $84 |
| Channel Medsystems, Inc. | 1 | $66 |
| Biogen | 2 | $54 |
| Organon | 2 | $40 |
| Merck | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Mimedx Group, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $33 |
| Exact Sciences | 1 | $30 |
| Avion Pharmaceuticals | 2 | $24 |
| Corcept Therapeutics | 1 | $21 |
| Bayer | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
How this compares
$1,674 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 121 | $3,206 |
| ValacyclovirValacyclovir Hcl | 37 | $1,132 |
| Medroxyprogesterone Acetate | 15 | $835 |
| Clobetasol Propionate | 19 | $775 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 30 | $687 |
| Raloxifene Hcl | 13 | $150 |
| Nystatin | 13 | $145 |
| Fluconazole | 24 | $106 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $97 |
| Metronidazole | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other family in Sebring
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.